Similar articles

• Linkage of a triple helix-forming oligonucleotide to amsacrine-4-carboxamide derivatives modulates the sequence-selectivity of topoisomerase II-mediated DNA cleavage.

  Arimondo P, Bailly C, Boutorine A, Asseline U, Sun JS, Garestier T, Hélène C. Arimondo P, et al. Nucleosides Nucleotides Nucleic Acids. 2000 Aug;19(8):1205-18. doi: 10.1080/15257770008033044. Nucleosides Nucleotides Nucleic Acids. 2000. PMID: 11097051
• DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors.

  Chen AY, Yu C, Gatto B, Liu LF. Chen AY, et al. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8131-5. doi: 10.1073/pnas.90.17.8131. Proc Natl Acad Sci U S A. 1993. PMID: 7690143 Free PMC article.
• Targeting DNA through-covalent interactions of reversible binding drugs.

  Graves DE. Graves DE. Methods Enzymol. 2001;340:377-95. doi: 10.1016/s0076-6879(01)40432-0. Methods Enzymol. 2001. PMID: 11494860 No abstract available.
• Camptothecins as probes of the microenvironments of topoisomerase I--DNA complexes.

  Hecht SM. Hecht SM. Ann N Y Acad Sci. 2000;922:76-91. doi: 10.1111/j.1749-6632.2000.tb07027.x. Ann N Y Acad Sci. 2000. PMID: 11193927 Review.
• Bacteriophage T4, a model system for understanding the mechanism of type II topoisomerase inhibitors.

  Kreuzer KN. Kreuzer KN. Biochim Biophys Acta. 1998 Oct 1;1400(1-3):339-47. doi: 10.1016/s0167-4781(98)00145-6. Biochim Biophys Acta. 1998. PMID: 9748648 Review.